{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:48Z","timestamp":1791920028645,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier","isbn-type":[{"value":"9780128234686","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.enz.2021.07.006","type":"book-chapter","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:42:14Z","timestamp":1634895734000},"page":"265-303","source":"Crossref","is-referenced-by-count":29,"title":["Flavivirus enzymes and their inhibitors"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.enz.2021.07.006_bb0010","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1128\/JVI.01257-06","article-title":"Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis","volume":"80","author":"Clyde","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0015","first-page":"299","article-title":"Epidemiology of dengue: past, present and future prospects","volume":"5","author":"Murray","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.enz.2021.07.006_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0030","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1128\/jvi.65.11.6042-6050.1991","article-title":"Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites","volume":"65","author":"Chambers","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0035","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0040","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2004.07.004","article-title":"The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core","volume":"328","author":"Benarroch","year":"2004","journal-title":"Virology"},{"key":"10.1016\/bs.enz.2021.07.006_bb0050","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1261\/rna.1609709","article-title":"The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure","volume":"15","author":"Issur","year":"2009","journal-title":"RNA"},{"key":"10.1016\/bs.enz.2021.07.006_bb0055","doi-asserted-by":"crossref","first-page":"39926","DOI":"10.1074\/jbc.M104248200","article-title":"De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase","volume":"276","author":"Ackermann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","article-title":"Structural biology of Zika virus and other flaviviruses","volume":"25","author":"Hasan","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.006_bb0080","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/jvi.71.9.6650-6661.1997","article-title":"Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures","volume":"71","author":"Westaway","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.enz.2021.07.006_bb0090","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1128\/JVI.00986-10","article-title":"The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex","volume":"84","author":"Gillespie","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0095","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.3390\/v7082837","article-title":"Flaviviral replication complex: coordination between RNA synthesis and 5'-RNA capping","volume":"7","author":"Klema","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/bs.enz.2021.07.006_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2015.08.002","article-title":"Flavivirus RNA synthesis in vitro","volume":"91","author":"Padmanabhan","year":"2015","journal-title":"Methods"},{"key":"10.1016\/bs.enz.2021.07.006_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0042-6822(78)90185-X","article-title":"Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses","volume":"89","author":"Wengler","year":"1978","journal-title":"Virology"},{"key":"10.1016\/bs.enz.2021.07.006_bb0110","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/bs.enz.2021.07.006_bb0115","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5","volume":"80","author":"Ray","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-pharmtox-011112-140254","article-title":"Direct-acting antiviral agents for hepatitis C virus infection","volume":"53","author":"Kiser","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0125","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.006_bb0130","doi-asserted-by":"crossref","first-page":"12883","DOI":"10.1074\/jbc.M611318200","article-title":"Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease","volume":"282","author":"Bera","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/BJ20051767","article-title":"Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides","volume":"397","author":"Niyomrattanakit","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/bs.enz.2021.07.006_bb0140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/acsinfecdis.6b00131","article-title":"Dengue protease substrate recognition: binding of the prime side","volume":"2","author":"Lin","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/bs.enz.2021.07.006_bb0145","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2021.07.006_bb0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/bs.enz.2021.07.006_bb0160","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1126\/science.aai9309","article-title":"Crystal structure of unlinked NS2B-NS3 protease from Zika virus","volume":"354","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.006_bb0165","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/bs.enz.2021.07.006_bb0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","article-title":"Strategies towards protease inhibitors for emerging flaviviruses","volume":"1062","author":"Nitsche","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of dengue virus ns3 protease. Part 1: warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2021.07.006_bb0180","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/jm800503y","article-title":"Potent cationic inhibitors of West Nile virus NS2B\/NS3 protease with serum stability, cell permeability and antiviral activity","volume":"51","author":"Stoermer","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.006_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1099\/00207713-52-3-823","article-title":"The search for synonyms among streptomycetes by using SDS-PAGE of whole-cell proteins. Emendation of the species Streptomyces aurantiacus, Streptomyces cacaoi subsp. cacaoi, Streptomyces caeruleus and Streptomyces violaceus","volume":"52","author":"Lanoot","year":"2002","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0205","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsmedchemlett.0c00100","article-title":"From bacteria to cancer: a benzothiazole-based DNA gyrase B inhibitor redesigned for Hsp90 C-terminal inhibition","volume":"11","author":"Pugh","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2021.07.006_bb0210","doi-asserted-by":"crossref","first-page":"31365","DOI":"10.1073\/pnas.2005463117","article-title":"Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors","volume":"117","author":"Abrams","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.006_bb0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.2011.01207.x","article-title":"Chronic treatment with a novel gamma-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease","volume":"163","author":"Van Broeck","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2017.07.019","article-title":"Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis","volume":"153","author":"Gur","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0225","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0230","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1751-1097.2011.00986.x","article-title":"Temoporfin (Foscan(R), 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)\u2014a second-generation photosensitizer","volume":"87","author":"Senge","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0235","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2741\/4038","article-title":"Superfamily 2 helicases","volume":"17","author":"Byrd","year":"2012","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/bs.enz.2021.07.006_bb0240","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the Dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A","volume":"79","author":"Xu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0245","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","article-title":"Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0250","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/emboj.2008.232","article-title":"Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein","volume":"27","author":"Luo","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/bs.enz.2021.07.006_bb0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1097-2765(01)00329-X","article-title":"DExD\/H box RNA helicases: from generic motors to specific dissociation functions","volume":"8","author":"Tanner","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.enz.2021.07.006_bb0260","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1432-1033.2004.04094.x","article-title":"Unraveling DNA helicases. Motif, structure, mechanism and function","volume":"271","author":"Tuteja","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature04331","article-title":"RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP","volume":"439","author":"Dumont","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2021.07.006_bb0270","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/bs.enz.2021.07.006_bb0275","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0280","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/cells9092100","article-title":"Ivermectin as a broad-spectrum host-directed antiviral: the real deal?","volume":"9","author":"Jans","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.enz.2021.07.006_bb0285","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/id5000458","article-title":"Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase","volume":"1","author":"Sweeney","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/bs.enz.2021.07.006_bb0290","doi-asserted-by":"crossref","first-page":"19949","DOI":"10.1074\/jbc.M113.463166","article-title":"Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis","volume":"288","author":"Sweeney","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0295","doi-asserted-by":"crossref","first-page":"34550","DOI":"10.1038\/srep34550","article-title":"Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus","volume":"6","author":"Fang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.enz.2021.07.006_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006103","article-title":"Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations","volume":"14","author":"Davidson","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0305","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1128\/JVI.02455-06","article-title":"Distinct RNA elements confer specificity to flavivirus RNA cap methylation events","volume":"81","author":"Dong","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0310","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/JVI.02202-07","article-title":"West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism","volume":"82","author":"Dong","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(03)00522-7","article-title":"Structure and mechanism of mRNA cap (guanine-N7) methyltransferase","volume":"13","author":"Fabrega","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.enz.2021.07.006_bb0320","doi-asserted-by":"crossref","first-page":"41978","DOI":"10.1074\/jbc.M205423200","article-title":"Active site in RrmJ, a heat shock-induced methyltransferase","volume":"277","author":"Hager","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0325","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130062","article-title":"Novel broad spectrum inhibitors targeting the flavivirus methyltransferase","volume":"10","author":"Brecher","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2021.07.006_bb0335","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1087057111412183","article-title":"A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development","volume":"16","author":"Geiss","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/bs.enz.2021.07.006_bb0340","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1128\/JVI.00384-12","article-title":"Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme","volume":"86","author":"Stahla-Beek","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130083","article-title":"Murine efficacy and pharmacokinetic evaluation of the flaviviral NS5 capping enzyme 2-thioxothiazolidin-4-one inhibitor BG-323","volume":"10","author":"Bullard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2021.07.006_bb0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2014.03.013","article-title":"Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery","volume":"106","author":"Coutard","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0355","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejmech.2018.09.056","article-title":"Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors","volume":"161","author":"Hernandez","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/34542","article-title":"A mechanism for all polymerases","volume":"391","author":"Steitz","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2021.07.006_bb0365","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1099\/vir.0.19731-0","article-title":"Initiation of viral RNA-dependent RNA polymerization","volume":"85","author":"van Dijk","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4614-0980-9_12","article-title":"Viral polymerases","volume":"726","author":"Choi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005451","article-title":"Dengue virus nonstructural protein 5 (NS5) assembles into a dimer with a unique methyltransferase and polymerase interface","volume":"12","author":"Klema","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.enz.2021.07.006_bb0380","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","article-title":"Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5","volume":"372","author":"Egloff","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0385","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/JVI.02283-06","article-title":"Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution","volume":"81","author":"Yap","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003549","article-title":"Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface","volume":"9","author":"Lu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.enz.2021.07.006_bb0395","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.sbi.2009.10.015","article-title":"RNA-dependent RNA polymerases from flaviviridae","volume":"19","author":"Choi","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0400","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0405","doi-asserted-by":"crossref","first-page":"104574","DOI":"10.1016\/j.antiviral.2019.104574","article-title":"Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-naive subjects","volume":"170","author":"Han","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0410","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","article-title":"Evaluation of Sofosbuvir (beta-D-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.enz.2021.07.006_bb0415","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.006_bb0420","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.enz.2021.07.006_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.enz.2021.07.006_bb0430","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","article-title":"BCX4430\u2014a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease","volume":"9","author":"Taylor","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/bs.enz.2021.07.006_bb0435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0440","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1128\/AAC.03368-14","article-title":"BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model","volume":"58","author":"Julander","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2021.07.006_bb0445","doi-asserted-by":"crossref","first-page":"eaau9135","DOI":"10.1126\/scitranslmed.aau9135","article-title":"A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques","volume":"12","author":"Lim","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.enz.2021.07.006_bb0450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2015.07.010","article-title":"The search for nucleoside\/nucleotide analog inhibitors of dengue virus","volume":"122","author":"Chen","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.006_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.enz.2021.07.006_bb0460","doi-asserted-by":"crossref","first-page":"e01028","DOI":"10.1128\/JVI.01028-17","article-title":"Escape of tick-borne flavivirus from 2\u2019-C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness","volume":"91","author":"Eyer","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0465","doi-asserted-by":"crossref","first-page":"e02093","DOI":"10.1128\/AAC.02093-18","article-title":"Viral RNA-dependent RNA polymerase inhibitor 7-deaza-2\u2019-C-methyladenosine prevents death in a mouse model of west nile virus infection","volume":"63","author":"Eyer","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2021.07.006_bb0470","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0475","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/ph12030101","article-title":"Antiviral agents in development for zika virus infections","volume":"12","author":"Baz","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/bs.enz.2021.07.006_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007894","article-title":"Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase","volume":"13","author":"Shimizu","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.enz.2021.07.006_bb0485","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","article-title":"Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design","volume":"59","author":"Yokokawa","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005737","article-title":"Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling","volume":"12","author":"Lim","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.enz.2021.07.006_bb0495","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-981-10-8727-1_14","article-title":"Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design","volume":"1062","author":"Lim","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0500","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1073\/pnas.0804276105","article-title":"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.006_bb0505","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a selective survival of motor neuron-2 ( SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.006_bb0510","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s40265-020-01410-z","article-title":"Risdiplam: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/bs.enz.2021.07.006_bb0515","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.chom.2018.10.011","article-title":"Integrative analysis of zika virus genome RNA structure reveals critical determinants of viral infectivity","volume":"24","author":"Li","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.enz.2021.07.006_bb0520","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1073\/pnas.1716689115","article-title":"Pervasive tertiary structure in the dengue virus RNA genome","volume":"115","author":"Dethoff","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.006_bb0525","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1128\/JVI.01647-08","article-title":"Structural and functional studies of the promoter element for dengue virus RNA replication","volume":"83","author":"Lodeiro","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0530","doi-asserted-by":"crossref","first-page":"e00047","DOI":"10.1128\/JVI.00047-17","article-title":"Interactions between the dengue virus polymerase NS5 and stem-loop A","volume":"91","author":"Bujalowski","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/bs.enz.2021.07.006_bb0535","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2008.10.007","article-title":"A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity","volume":"4","author":"Pijlman","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.enz.2021.07.006_bb0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.1250897","article-title":"The structural basis of pathogenic subgenomic flavivirus RNA (sfRNA) production","volume":"344","author":"Chapman","year":"2014","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.006_bb0545","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/s41467-021-22846-1","article-title":"Structures of flavivirus RNA promoters suggest two binding modes with NS5 polymerase","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."}],"container-title":["The Enzymes","Viral Replication Enzymes and their Inhibitors Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:17:26Z","timestamp":1753888646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604721000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128234686"],"references-count":108,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2021.07.006","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}